
Geneviève Gourdon
86
Documents
Publications
Publications
Treatment of myotonic dystrophy type 1 with CRISPR/Cas9SFTCG, Mar 2024, Nantes (France), France
Communication dans un congrès
hal-04541390
v1
|
|
Identification of CTG.CAG contraction factors in Myotonic Dystrophy type 1FASEB, The dynamic DNA structures in biology conference, Jun 2022, Nova Scotia, Canada
Communication dans un congrès
hal-04004392
v1
|
|
Identification of CTG.CAG contraction factors in Myotonic Dystrophy type 1International Myotonic Dystrophy consortium Meeting 13, Jun 2022, Osaka, Japan
Communication dans un congrès
hal-04004375
v1
|
|
Identification of a CCG-enriched expanded allele in DM1 patients using Amplification-free long-read sequencingFASEB, The dynamic DNA structures in biology conference, Jun 2022, Nova Scotia, Canada
Communication dans un congrès
hal-04004408
v1
|
|
Identification of a CCG-enriched expanded allele in DM1 patients using Amplification-free long-read sequencingPacBio users 2022, May 2022, Paris, France
Communication dans un congrès
hal-04004337
v1
|
|
Overviews of mouse models for myotonic dystrophySeminar, Target Laboratory, Nantes, Jun 2022, Nantes (visioconférence), France
Communication dans un congrès
hal-04007452
v1
|
|
Glial cell dysfunction in myotonic dystrophy brain disease12th Japanese-French Workshop: New insights in personalized medicine for neuromuscular diseases: From Basic to Applied Myology, Sep 2022, Giverny, France
Communication dans un congrès
hal-04004421
v1
|
|
Identification of CTG.CAG contraction factors in Myotonic Dystrophy type 119ème Journées de la Société Française de Myologie (JSFM), Nov 2022, Toulouse, France
Communication dans un congrès
hal-04004435
v1
|
|
Overviews of mouse models for myotonic dystrophySeminar, Biogen, 2021, Web Conference, United States
Communication dans un congrès
hal-04007479
v1
|
|
Overviews of mouse models for myotonic dystrophySeminar, Bayer AG, Jan 2021, Web Conference, Germany
Communication dans un congrès
hal-04007484
v1
|
|
Identification of CTG.CAG contraction factors in Myotonic Dystrophy type 1Société Française de Myologie (SFM), Jan 2021, Paris, France
Communication dans un congrès
hal-04003579
v1
|
|
Overviews of mouse models for myotonic dystrophySeminar, Askbio, Dec 2021, Web Conference, United States
Communication dans un congrès
hal-04007474
v1
|
|
Identification de nouveaux facteurs de contractions CTG dans la DM118ème Journées de la Société Française de Myologie (JSFM), Nov 2021, Saint Etienne, France
Communication dans un congrès
hal-04004288
v1
|
|
Identification of CTG.CAG contraction factors in Myotonic Dystrophy type 1Expanded repeat disorders: from mechanisms to therapies, Jun 2021, Cardiff, United Kingdom
Communication dans un congrès
hal-04004162
v1
|
|
How SMRT sequencing can improve the prognosis and genetic counseling in DM1 patientExpanded repeat disorders: from mechanisms to therapies, Jun 2021, Cardiff, United Kingdom
Communication dans un congrès
hal-04004237
v1
|
|
How SMRT sequencing can improve the prognosis and genetic counseling in DM1 patientsSeminar, PacBio Neuroscience day, Dec 2020, Web Conference, United States
Communication dans un congrès
hal-04007488
v1
|
|
How SMRT sequencing can improve the prognosis and genetic counseling in DM1 patientsNeuroscience PacBio day 2020, Dec 2020, Paris, France
Communication dans un congrès
hal-04004354
v1
|
|
DMSXL mice adults and neonatal featuresENMC International Workshop on Myotonic Dystrophies, Oct 2019, Amsterdam, Netherlands
Communication dans un congrès
hal-04003520
v1
|
|
Overview of DMSXL: pros & consMyotonic Annual Conference, Oct 2019, Philadelphia, United States
Communication dans un congrès
hal-04003513
v1
|
|
Overview of the DMSXL mouse model of DM1: From DNA repair to phenotypeSeminar, Institute of Biochemistry and Cell Biology, National Research Council, Sep 2019, Rome, Italy
Communication dans un congrès
hal-04007495
v1
|
|
Real-time monitoring of brain cell models for neuromuscular and neurodegenerative disordersIncucyte User Meeting, Nov 2019, Paris, France
Communication dans un congrès
hal-04003539
v1
|
|
Investigating oligodendrocyte dysfunction in DM1 brain disease4th Congress of the Young Researchers of Imagine Institute, May 2018, Paris, France
Communication dans un congrès
hal-04003498
v1
|
|
Investigating oligodendrocyte dysfunction in DM1 brain diseaseInternational Conference on Unstable Microsatellites and Human Disease, Apr 2018, Capri (IT), Italy
Communication dans un congrès
hal-04003486
v1
|
|
Investigating the mechanisms of brain disease in a mouse model of myotonic dystrophyMDRU meeting, Mar 2017, Munich, Germany
Communication dans un congrès
hal-04001746
v1
|
|
Investigating oligodendrocyte dysfunction in DM1 brain diseaseImagine Young Researcher Seminars, Feb 2017, Paris, France
Communication dans un congrès
hal-04001598
v1
|
|
DMSXL mouse model of myotonic dystrophy: past present and futureSeminar, Centre de recherche en myologie, Mar 2017, Paris, France
Communication dans un congrès
hal-04007503
v1
|
|
Abnormal neuroglial interactions in myotonic dystrophy Young Researchers in Life Sciences, May 2017, Paris, France
Communication dans un congrès
hal-04001772
v1
|
|
CUG RNA toxicity in astrocytes is associated with adhesion and migration deficits and affects neuritogenesisInternational Myotonic Dystrophy consortium Meeting 11, Sep 2017, San Francisco (CA, USA), United States
Communication dans un congrès
hal-04003470
v1
|
|
Atypical Myotonic Dystrophy type 1 families and CTG repeat contractionsImagine Young Researcher Seminars, Mar 2017, Paris, France
Communication dans un congrès
hal-04001726
v1
|
Myotonic dystrophy RNA toxicity alters morphology, adhesion and migration of mouse and human astrocytes2022
Pré-publication, Document de travail
hal-03863376
v1
|
Chargement...
Chargement...